Literature DB >> 2623783

Pathology and pathophysiology of painful bladder diseases.

M Holm-Bentzen1.   

Abstract

Painful bladder disease is an ill-defined disease presenting with chronic cystitis symptoms, despite sterile urine. This report includes only patients with painful bladder diseases of unknown etiology and pathogenesis. We have chosen to classify these patients pathoanatomically as follows: interstitial cystitis, detrusor myopathy, chronic unspecific cystitis and eosinophilic cystitis. The pathoanatomical appearance of the four groups of patients are described in details and certain clinical differences appear between the groups. The etiology and pathogenesis to the inflammatory reactions and muscle changes found in the detrusor biopsies are unknown, but many theories exist. It is suggested that something in the urine gains access to the bladder wall and initiates the pathoanatomical changes through a defective urothelium and glycosaminoglycans layer. In the interstitial cystitis patients, the inflammatory process and mast cell degranulation might be monitored by the urinary excretion of 1,4-methyl-imidazole-acetic acid and eosinophil cationic protein. It is concluded that no specific therapy for the disease exists, since etiology and pathogenesis are still unknown and therefore future research in this field is very important.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2623783     DOI: 10.1159/000281535

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  2 in total

1.  Severe unremitting cystitis progressing to cystectomy.

Authors:  S R Keoghane; N Gubbay; R B Kinder
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

2.  MCP-1-induced histamine release from mast cells is associated with development of interstitial cystitis/bladder pain syndrome in rat models.

Authors:  Jianwei Lv; Yiran Huang; Shiguo Zhu; Ganggang Yang; Yujian Zhang; Jing Leng; Juanjie Bo; Dongming Liu
Journal:  Mediators Inflamm       Date:  2012-09-19       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.